SCHEMBL424240

SCHEMBL424240

CC(COC=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.47
AOC3 Q16853 2/20 0.42
TRPA1 O75762 4/20 0.41
RIPK1 Q13546 1/20 0.41
KMT2A Q03164 1/20 0.38
IGLV6-57 P01721 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8470436 0.89 GRIA4 (0.46) TAAR1
SCHEMBL2927957 0.81 CA12 (0.42) TAAR1KMT2A
SCHEMBL23315604 0.81 TYR (0.31)
SCHEMBL9572888 0.81 RIPK1 (0.47) TAAR1AOC3TRPA1RIPK1
Ethoxycarbonyl Group SCHEMBL27800290 0.79 ALDH1A1 (0.42) TAAR1AOC3TRPA1RIPK1
SCHEMBL10136496 0.78 NPSR1 (0.39) TAAR1TRPA1KMT2A
SCHEMBL2092260 0.78 RIPK1 (0.44) TAAR1AOC3TRPA1RIPK1
SCHEMBL4964891 0.78 CYP2D6 (0.37) TAAR1KMT2A
SCHEMBL11124283 0.77 KMT2A (0.40) KMT2A
SCHEMBL7232754 0.77 CCR5 (0.41) TAAR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4201707-A Methine dyestuffs containing a phenyl azo group BAYER AKTIENGESELLSCHAFT (DE) 1980-05-06 US claimed
US-4138570-A METHINE DYE BAYER AKTIENGESELLSCHAFT (DE) 1979-02-06 US claimed
US-20250049660-A1 ENOL ETHER PROPERFUME FIRMENICH SA (CH) 2025-02-13 US disclosed
EP-4416125-A1 ENOL ETHER PROPERFUME Firmenich SA (CH) 2024-08-21 EP disclosed
WO-2024075815-A1 8-HYDROXYQUINOLINE COMPOUND AND USE THEREOF 国立大学法人大阪大学 2024-04-11 WO disclosed
WO-2023111006-A1 ENOL ETHER PROPERFUME FIRMENICH SA (CH) 2023-06-22 WO disclosed
US-20210309619-A1 ISOXAZOLIN-5-ONE DERIVATIVES AND HERBICIDES CONTAINING THE SAME AS ACTIVE INGREDIENTS HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2021-10-07 US disclosed
US-11109593-B2 Isoxazolin-5-one derivative and herbicide containing same as active ingredient HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2021-09-07 US disclosed
EP-3828176-A1 ISOXAZOLIN-5-ONE DERIVATIVE, AND HERBICIDE CONTAINING SAME AS ACTIVE INGREDIENT Hokko Chemical Industry Co., Ltd. (JP) 2021-06-02 EP disclosed
US-20200267985-A1 ISOXAZOLIN-5-ONE DERIVATIVE AND HERBICIDE CONTAINING SAME AS ACTIVE INGREDIENT HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2020-08-27 US disclosed
WO-2020022350-A1 ISOXAZOLIN-5-ONE DERIVATIVE, AND HERBICIDE CONTAINING SAME AS ACTIVE INGREDIENT 北興化学工業株式会社 2020-01-30 WO disclosed
US-4933355-A ALDOSE REDUCTASE INHIBITORS SANKYO COMPANY LIMITED (JP) 1990-06-12 US disclosed
EP-0337819-A1 Thiazole derivatives, their preparation and their use in the treatment of diabetes complications Sankyo Company Limited (JP) 1989-10-18 EP disclosed
US-4859759-A Siloxane containing benzotriazolyl/tetraalkylpiperidyl substituent KIMBERLY-CLARK CORPORATION (US) 1989-08-22 US disclosed
EP-0135349-B1 CONDENSED SEVEN-MEMBERED RING COMPOUNDS AND THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1988-11-02 EP disclosed
US-4591458-A ENZYME INHIBITORS; HYPOTENSIVE AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1986-05-27 US disclosed
US-4584303-A ANALGESICS THE BOC GROUP, INC. (US) 1986-04-22 US disclosed
EP-0160422-A1 N-Aryl-N-(4-Piperidinyl)amides and pharmaceutical compositions and methods employing such compounds Anaquest, Inc. (US) 1985-11-06 EP disclosed
US-4548932-A ANGIOTENSIN INHIBITOR, HYPOTENSIVE AGENT TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-10-22 US disclosed
EP-0135349-A1 Condensed seven-membered ring compounds and their production and use Takeda Chemical Industries, Ltd. (JP) 1985-03-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200267985-A1 ISOXAZOLIN-5-ONE DERIVATIVE AND HERBICIDE CONTAINING SAME AS ACTIVE INGREDIENT HAX1, CYP4X1, CANX TAAR1 2133/4885AOC3 1126/4885TRPA1 727/4885
US-20250049660-A1 ENOL ETHER PROPERFUME CYP2E1, ADH5, ECI1 TAAR1 2605/4885AOC3 345/4885TRPA1 882/4885
US-11109593-B2 Isoxazolin-5-one derivative and herbicide containing same as active ingredient HAX1, CYP4X1, CANX TAAR1 2133/4885AOC3 1126/4885TRPA1 727/4885
US-20210309619-A1 ISOXAZOLIN-5-ONE DERIVATIVES AND HERBICIDES CONTAINING THE SAME AS ACTIVE INGREDIENTS HAX1, CYP4X1, CNPY2 TAAR1 2015/4885AOC3 437/4885TRPA1 1054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.